Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Change in Cash: 2017-2025

Historic Change in Cash for Arcus Biosciences (RCUS) over the last 9 years, with Sep 2025 value amounting to -$10.0 million.

  • Arcus Biosciences' Change in Cash fell 122.22% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 117.65%. This contributed to the annual value of $23.0 million for FY2024, which is 129.11% up from last year.
  • As of Q3 2025, Arcus Biosciences' Change in Cash stood at -$10.0 million, which was down 117.86% from $56.0 million recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Change in Cash peaked at $401.0 million during Q1 2022, and registered a low of -$276.0 million during Q2 2022.
  • Moreover, its 3-year median value for Change in Cash was -$8.0 million (2023), whereas its average is $2.9 million.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 2,228.58% in 2021, then slumped by 375.00% in 2023.
  • Arcus Biosciences' Change in Cash (Quarterly) stood at -$31.8 million in 2021, then spiked by 62.29% to -$12.0 million in 2022, then slumped by 375.00% to -$57.0 million in 2023, then increased by 10.53% to -$51.0 million in 2024, then crashed by 122.22% to -$10.0 million in 2025.
  • Its last three reported values are -$10.0 million in Q3 2025, $56.0 million for Q2 2025, and $42.0 million during Q1 2025.